The debate over banning or legalizing marijuana has been going on for greater than a century now, but it remains a new issue on the table. There are people who strongly support its legalization, while there are many who vehemently oppose it. However, over the last decade, the debate has been tilted and only cannabis as the term “medical marijuana” has gained momentum with the aid of legalization campaigns. Still, you will find others who are preventing it from going all of it legal.
The findings of a recent study also go and only optimum medical usage of marijuana. It says a certain chemical found in marijuana can actually assist in treating patients with drug-resistant types of epilepsy. This new study has provided evidence that marijuana can be effective in treatment for one-third of epilepsy patients who have a treatment-resistant type of the disease.
The research titled “Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial” – published in The Lancet Neurology – says that almost one-third of epilepsy patients are treatment-resistant and are associated with severe morbidity and increased mortality. How does 750mg CBD Gummies compare against 250mg, 500mg and 750mg CBD gummy bears? Though marijuana-based treatments for epilepsy have spiked the interest of the people, scientific data about them is very limited, have the authors.
“We aimed to determine whether addition of cannabidiol to existing anti-epileptic regimens could be safe, tolerated, and efficacious in children and teenagers with treatment-resistant epilepsy,” the researchers said.
The researchers, led by Orrin Devinsky, neurologist at New York University Langone Medical Center, administered an extract of 99 percent cannabidiol (CBD) – a non-psychoactive chemical in marijuana – to 162 patients and monitored them for around 12 weeks. The chemical was presented with as a product or add-on as well as other preexisting medicines of the patients and was conducted on an open level, which means everybody was alert to what they certainly were given. The researchers observed that intervention managed to cut back to motor seizures at a similar rate by the existing drugs, but 2 percent of patients became completely seizure free.
Despite some positive results being shown by this method, the researchers feel that there’s need for further extensive studies on the subject. “Our findings claim that cannabidiol might reduce seizure frequency and might have a satisfactory safety profile in children and teenagers with highly treatment-resistant epilepsy. Randomized controlled trials are warranted to characterize the safety profile and true efficacy with this compound,” the study said.
This is not initially when this kind of observation has been made. Some previous studies had also drawn similar conclusions. A 2007 study, titled “Marijuana: An Effective Antiepileptic Treatment in Partial Epilepsy? A Case Report and Report on the Literature,” published in the Reviews in Neurological Diseases had also said that “marijuana or its active constituents could have a devote the treating partial epilepsy.”
Katherine Mortati, M.D., a neurologist at the Comprehensive Epilepsy Center at SUNY Downstate Medical Center, who had conducted the study, said “In the study we present the case of a 45-year-old man with cerebral palsy and epilepsy who showed marked improvement with the use of marijuana. This case supports other anecdotal data suggesting that marijuana use can be a beneficial adjunctive treatment in a few patients with epilepsy.”
Even The British Epilepsy Association had said in 2006 that “there’s scientific evidence to claim that cannabis may be beneficial in treating numerous conditions, including epilepsy.”
More studies need to be done to get proof of marijuana’s utility in coping with epilepsy. Even though proved, marijuana will continue to be an addictive substance, that might have several side effects, like hallucinations, cravings and drug seeking behavior.